This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Alembic Limited. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2011
Title: Hitarth Harshendu Acharya: Innovator in Pharmaceutical Purification Processes
Introduction
Hitarth Harshendu Acharya is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the purification processes of various compounds. With a total of 4 patents to his name, Acharya continues to push the boundaries of innovation in his field.
Latest Patents
Acharya's latest patents focus on the purification of Ropinirole hydrochloride, a medication used to treat Parkinson's disease. The first patent describes an improved process that involves dissolving ropinirole hydrochloride in water, treating the solution with sodium dithionate and charcoal, and isolating the free base through a series of steps. The second patent outlines a similar process but emphasizes the use of suitable alcoholic solvents and ethanol for the purification of the compound. These innovations demonstrate Acharya's commitment to enhancing pharmaceutical manufacturing processes.
Career Highlights
Hitarth Acharya is currently employed at Alembic Limited, a prominent pharmaceutical company known for its research and development in drug manufacturing. His work at Alembic has allowed him to collaborate with other talented professionals in the industry, furthering his impact on pharmaceutical innovations.
Collaborations
Acharya has worked alongside esteemed colleagues such as Pandurang Balwant Deshpande and Parven Kumar Luthra. Their collaborative efforts have contributed to the advancement of purification techniques in the pharmaceutical sector.
Conclusion
Hitarth Harshendu Acharya is a distinguished inventor whose work in the purification of pharmaceutical compounds is paving the way for more efficient drug manufacturing processes. His contributions are vital to the ongoing evolution of the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
